| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/12/2008 | EP1896502A1 Treatment of fungal and/or protist infections |
| 03/12/2008 | EP1896501A2 Peptidic antagonists of class iii semaphorins/neuropilins complexes |
| 03/12/2008 | EP1896500A2 Gliomedin, fragments thereof and methods of using same |
| 03/12/2008 | EP1896499A2 Hecgf-1 related polymorphisms and applications thereof |
| 03/12/2008 | EP1896498A2 Epitope analogues |
| 03/12/2008 | EP1896497A2 Method for diagnosing rheumatic diseases |
| 03/12/2008 | EP1896496A2 Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes |
| 03/12/2008 | EP1896495A2 Dkkl-1 splice product modulators for cancer diagnosis and therapy |
| 03/12/2008 | EP1896494A2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| 03/12/2008 | EP1896493A1 A device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 03/12/2008 | EP1896386A1 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria |
| 03/12/2008 | EP1896082A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| 03/12/2008 | EP1896080A2 Toxin peptides with extended blood halflife |
| 03/12/2008 | EP1896069A2 Inactivated chimeric vaccines and related methods of use |
| 03/12/2008 | EP1896060A1 Anti-malaria vaccine |
| 03/12/2008 | EP1896047A1 Anti-gfralpha3 antibodies |
| 03/12/2008 | EP1789440A4 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 03/12/2008 | EP1705182A4 Antitumoral and antiviral peptides |
| 03/12/2008 | EP1682866A4 Gel-shell beads with adsorbed or bound biomolecules |
| 03/12/2008 | EP1668031B1 Homogeneous preparations of il-29 |
| 03/12/2008 | EP1629003B1 Methods for identifying inhibitors |
| 03/12/2008 | EP1594896B1 Modified soluble t cell receptor |
| 03/12/2008 | EP1578791B1 Inclusion bodies for the oral vaccination of animals |
| 03/12/2008 | EP1506317B1 Marker molecules associated with lung tumors |
| 03/12/2008 | EP1278855B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/12/2008 | EP1225184B1 Human antithrombin variants |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP1049791B1 Methods and composition for modulating flavonoid content |
| 03/12/2008 | EP1045702B1 Methods of controlling cell differentiation and growth using a fusion protein and a drug |
| 03/12/2008 | EP1037657B1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 03/12/2008 | EP1032834B1 Nuclear hormone receptor drug screens |
| 03/12/2008 | EP0973538B1 Modified proteins which bind extracellular matrix components |
| 03/12/2008 | EP0972048B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/12/2008 | EP0907080B1 Method for assaying antigen relating to mental stress disorders |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | EP0833659B1 Therapeutic fragments of von willebrand factor |
| 03/12/2008 | EP0691982B2 Separation of proteins |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142614A Single channel image deformation system and method using anisotropic filtering |
| 03/12/2008 | CN101142235A Estrogen receptor structure |
| 03/12/2008 | CN101142234A Novel peptides that bind to the erythropoietin receptor |
| 03/12/2008 | CN101142233A Agents inhibiting the cathelin-like protein hcap18/ll-17 |
| 03/12/2008 | CN101142232A KUNITZ-type recombinant inhibitor |
| 03/12/2008 | CN101142231A Expression of defensins in filamentous fungi |
| 03/12/2008 | CN101142230A Yersinia spp. polypeptides and methods of use |
| 03/12/2008 | CN101139608A Cultivated silkworm microspore ATP-ADP carrier protein gene |
| 03/12/2008 | CN101139607A Cultivated silkworm microsporidian polar tube protein PTP1 gene |
| 03/12/2008 | CN101139606A Cultivated silkworm microsporidian water channel protein gene |
| 03/12/2008 | CN101139604A Turf grass stunt related gene GA20 |
| 03/12/2008 | CN101139603A Cultivated silkworm bmspz-like gene |
| 03/12/2008 | CN101139602A Cultivated silkworm sugar receptor protein gene Bmor1 |
| 03/12/2008 | CN101139601A HLH transcription control factor BmHLH1 for cultivated silk gland specification expression |
| 03/12/2008 | CN101139600A Cultivated silkworm antibiotic protein gene |
| 03/12/2008 | CN101139599A Cultivated silkworm peptidoglycan identification protein gene |
| 03/12/2008 | CN101139596A bmimd gene of cultivated silkworm heredo-immunity signal approach |
| 03/12/2008 | CN101139595A Cultivated silkworm PIWI gene |
| 03/12/2008 | CN101139593A House fly antibiotic peptide gene and sifting clone method |
| 03/12/2008 | CN101139592A Sequence and preparation method for novel signal conus O-superfamily toxin and uses thereof |
| 03/12/2008 | CN101139590A Hybrid expression of neisserial proteins |
| 03/12/2008 | CN101139587A Method for preparing phycoerythrobilin fluorescent protein |
| 03/12/2008 | CN101139393A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139392A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139391A CD147 extracellular domain crystal structure and use thereof |
| 03/12/2008 | CN101139390A Pig gamma interferon and encoding genes and use thereof |
| 03/12/2008 | CN101139389A Pig fat deposition related protein and encoding genes and use thereof |
| 03/12/2008 | CN101139388A Purification renaturation method for antineoplastic medicine TAT(m)-Survivin(T34A) |
| 03/12/2008 | CN101139387A Recombinant soluble human FGFR2 extracellular fragment and production method and application thereof |
| 03/12/2008 | CN101139386A Dicer protein having RNaseIII enzymatic activity and encoding gene and application thereof |
| 03/12/2008 | CN101139385A Vegetable stress-resistant related protein and its coding gene and application |
| 03/12/2008 | CN101139383A C end modification endomorphin 2 |
| 03/12/2008 | CN100374864C diagnostic kit using beta ig-h3 protein |
| 03/12/2008 | CN100374571C Regulatory sequences and expression system functioning in filamentous fungi |
| 03/12/2008 | CN100374566C Genes for the biosynthesis of epothilones |
| 03/12/2008 | CN100374565C Genes for biosynthesis of EPOTHILONE |
| 03/12/2008 | CN100374563C Attenuated pestiviruses |
| 03/12/2008 | CN100374562C Modified Cry3A toxins and nucleic acid sequences coding thereof |
| 03/12/2008 | CN100374560C Configuration of high effect expression serum albumin yeast strain and fermentation purification technology |
| 03/12/2008 | CN100374552C Method of large scale production of hepatitis a virus |
| 03/12/2008 | CN100374462C Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use |
| 03/12/2008 | CN100374461C Glucagon-like peptide-2 and its therapeutic use |
| 03/12/2008 | CN100374456C Specific human antibodies for selective cancer therapy |
| 03/12/2008 | CN100374151C medicine compositions for generating immune and usage of prevention and treatment of amyloidogenic disease |
| 03/12/2008 | CN100374036C Flax protein isolate and production |
| 03/11/2008 | US7342148 Gene and peptide for transcriptional repressor |
| 03/11/2008 | US7342109 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 03/11/2008 | US7342107 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines |
| 03/11/2008 | US7342105 Antibody and use thereof |
| 03/11/2008 | US7342103 Comprises DNAX interferon-like receptor subunit (DIRS) polypeptide for use in diagnosis and treatment of inflammation and blood disorders |
| 03/11/2008 | US7342102 Nucleotide sequences coding uncoupling protein for use in the diagnosis and treatment of nervous system disorders |
| 03/11/2008 | US7342100 Hpr6 mutants and uses thereof |
| 03/11/2008 | US7342099 cDNA encoding a gene BOG (B5T over-expressed gene) and its protein product |
| 03/11/2008 | US7342097 PRO1309 polypeptides |
| 03/11/2008 | US7342096 PRO1879 polypeptide |
| 03/11/2008 | US7342092 Vaccines as dosage forms; acute myeloblastic leukemia |
| 03/11/2008 | US7342091 Soluble cyclic analogues of β amyloid peptide |
| 03/11/2008 | US7342090 Peptide-mimetics are constrained in the three-dimensional structure to provide an increased immunogenicity to the epitope sequence |
| 03/11/2008 | US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/11/2008 | US7341998 Conus californicus neurotoxins |
| 03/11/2008 | US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders |
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |